INTERMACS and MedaMACS: How Will They Guide Future Therapy?
- 420 Downloads
The INTERMACS registry has played a central role in the evolving field of device therapy for advanced heart failure (HF). This nationwide, prospective registry of approved assist devices has defined the boundaries of mechanical support, tracked the evolution from pulsatile to continuous flow, developed new profiles for advanced HF, and standardized adverse event definitions. INTERMACS has guided current therapy and in the future will do so aided by new insights from MedaMACS, a parallel registry of medically-managed ambulatory patients with advanced HF. Together INTERMACS and MedaMACS will leverage the power of observation research to guide patient-centered decisions about mechanical circulatory support.
KeywordsHeart failure Heart assist devices Cardiomyopathy Registries INTERMACS MedaMACS Therapy
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.• Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200. Clinical trial of a novel, intrapericardial VAD (HeartWare HVAD) showed that the device is non-inferior to contemporaneously implanted bridging LVADs in the INTERMACS registry.PubMedCrossRefGoogle Scholar
- 9.•• Kirklin JK, Naftel DC, Kormos RL, et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31:117–26. The latest registry report from INTERMACS documents expanded LVAD use as destination therapy and outlines current risk factors for pump implantation.PubMedCrossRefGoogle Scholar
- 10.Cowger J, Kittleson M, Patel C, et al. End stage heart failure: are we missing patients who may benefit from left ventricular assist device support? Circulation. 2011;124:A8490.Google Scholar
- 11.Kittleson M, Stewart GC, Cowger J, et al. Need for triage in advanced heart failure. Circulation. 2012;126, A14709.Google Scholar
- 14.National Coverage Determination (NCD) Manual 100–03 20.9, Version 5, "Artificial Hearts and Related Devices", Implemented 1/6/2011Google Scholar
- 15.• Miller MA, Ulisney K, Baldwin JT. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support): a new paradigm for translating registry data into clinical practice. J Am Coll Cardiol. 2010;56:738–40. Cogent outline of the novel way INTERMACS leverages observational research to shape clinical practice patterns.PubMedCrossRefGoogle Scholar
- 16.www.uab.edu/intermacs (Accessed January 2013).
- 21.• Boyle AJ, Ascheim DD, Russo MJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant. 2012;30:402–7. Shows that INTERMACS profiling before pump implant can confer information about downstream risks, highlighting the relevance of this convenient new shorthand for describing advanced heart failure.CrossRefGoogle Scholar
- 27.Holman WL, Kirklin JK, Naftel DC, et al. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiov Sur. 2010;139(1632–6):e2.Google Scholar
- 34.• Acker MA, Pagani FD, Stough WG, et al. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant. 2012;31:1241–52. Position statement that discusses, amongst other things, the role for registries in pump approval and potential streamlining of device indications to either bridging therapy or treatment of heart failure.PubMedCrossRefGoogle Scholar
- 48.• Grady KL, Warner Stevenson L, Pagani FD, et al. Beyond survival: recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant. 2012;31:1158–64. Highlights the importance of routinely assessing exercise capacity and health-related quality of life in developing metrics of device benefit beyond survival alone.PubMedCrossRefGoogle Scholar
- 51.www.clinicaltrials.gov; NCT01452802 (Accessed January 2013).